96 related articles for article (PubMed ID: 2516374)
1. Analysis of the cytotoxic function of the thymocytes generated in a 14-day old mouse fetal thymus organ culture with high dose of IL-2.
Leclercq G; de Smedt M; Tison B; Plum J
Thymus; 1989; 13(1-2):95-102. PubMed ID: 2516374
[TBL] [Abstract][Full Text] [Related]
2. Murine trophoblast can be killed by lymphokine-activated killer cells.
Drake BL; Head JR
J Immunol; 1989 Jul; 143(1):9-14. PubMed ID: 2499634
[TBL] [Abstract][Full Text] [Related]
3. Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.
Plum J; De Smedt M; Leclercq G
J Immunol; 1993 Apr; 150(7):2706-16. PubMed ID: 8095954
[TBL] [Abstract][Full Text] [Related]
4. Expansion of large granular lymphocytes in IL-2-driven 14-day-old fetal thymocytes in organ culture.
Plum J; Koning F; Leclercq G; Tison B; De Smedt M
J Immunol; 1990 May; 144(10):3710-7. PubMed ID: 1970591
[TBL] [Abstract][Full Text] [Related]
5. Lymphokine-activated killer cell activity of CD4-CD8- TCR alpha beta + thymocytes.
Arase H; Arase-Fukushi N; Good RA; Onoé K
J Immunol; 1993 Jul; 151(2):546-55. PubMed ID: 8335898
[TBL] [Abstract][Full Text] [Related]
6. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
Mulé JJ; Krosnick JA; Rosenberg SA
J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
[TBL] [Abstract][Full Text] [Related]
7. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
Donskov F; Basse PH; Hokland M
Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killing by human intestinal lymphocytes.
Ebert EC; Roberts AI
Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
[TBL] [Abstract][Full Text] [Related]
10. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
Vujanovic NL; Herberman RB; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
[TBL] [Abstract][Full Text] [Related]
11. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.
Ballas ZK; Rasmussen W
J Immunol; 1993 Jan; 150(1):17-30. PubMed ID: 7678028
[TBL] [Abstract][Full Text] [Related]
12. Modulation of T-cell differentiation in murine fetal thymus organ cultures.
Waanders GA; Godfrey DI; Boyd RL
Thymus; 1989; 13(1-2):73-82. PubMed ID: 2516373
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of thymocytes in fetal organ culture: lack of evidence for the functional role of the interleukin 2 receptor expressed by prothymocytes.
Plum J; De Smedt M
Eur J Immunol; 1988 May; 18(5):795-9. PubMed ID: 3132397
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
16. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional heterogeneity of thymic and splenic lymphokine activated killer cells relative to ornithine sensitivity.
Mehrotra P; Bear HD; Susskind BM
Cell Immunol; 1991 Feb; 132(2):451-65. PubMed ID: 1899052
[TBL] [Abstract][Full Text] [Related]
18. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
Tilden AB; Itoh K; Balch CM
J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
[TBL] [Abstract][Full Text] [Related]
19. IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing alpha beta or gamma delta T-cell receptors in vitro: synergism with IL-2.
Okazaki H; Ito M; Sudo T; Hattori M; Kano S; Katsura Y; Minato N
J Immunol; 1989 Nov; 143(9):2917-22. PubMed ID: 2572646
[TBL] [Abstract][Full Text] [Related]
20. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T
Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]